Literature DB >> 3156242

Effects of diacetyl monoxime on cardiac excitation-contraction coupling.

T Li, N Sperelakis, R E Teneick, R J Solaro.   

Abstract

Diacetyl monoxime (DAM) is a negative inotropic agent. To identify the mechanism of its actions, electrical and mechanical studies with various cardiac tissues were carried out. DAM (0.2-20 mM) inhibited the contractile force in both normal and 22 mM KCl-depolarized (in presence of 10(-6) M isoproterenol) guinea-pig papillary muscles in a concentration-dependent manner. In general, there was a lack of major effects of DAM on sarcolemmal electrical properties. The fast action potentials were somewhat depressed and the slow action potentials were slightly enhanced. In chemically skinned pig ventricular muscles, the myofibrillar contraction induced in 6.25 pCa was inhibited by DAM in a similar concentration range. DAM also produced an apparent decrease in sensitivity toward Ca++ in this preparation. Myofibrillar adenosine triphosphatase assay showed similar results as in the skinned muscles. All DAM effects were reversible upon washout and could be partially antagonized by raising [Ca++]. Taken together, the negative inotropic effect of DAM cannot be ascribed to an inhibitory effect on the slow inward current, as suggested previously. An inhibitory effect at the myofibril level is a distinct possibility. Additional effects of DAM on the sarcoplasmic reticulum cannot be ruled out.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3156242

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  48 in total

1.  Optical transmembrane potential recordings during intracardiac defibrillation-strength shocks.

Authors:  D M Clark; A E Pollard; R E Ideker; S B Knisley
Journal:  J Interv Card Electrophysiol       Date:  1999-07       Impact factor: 1.900

2.  Roles of electric field and fiber structure in cardiac electric stimulation.

Authors:  S B Knisley; N Trayanova; F Aguel
Journal:  Biophys J       Date:  1999-09       Impact factor: 4.033

3.  Effects of elevated extracellular potassium on the stimulation mechanism of diastolic cardiac tissue.

Authors:  Veniamin Y Sidorov; Marcella C Woods; John P Wikswo
Journal:  Biophys J       Date:  2003-05       Impact factor: 4.033

Review 4.  Optical mapping in the developing zebrafish heart.

Authors:  M Khaled Sabeh; Hussein Kekhia; Calum A Macrae
Journal:  Pediatr Cardiol       Date:  2012-03-30       Impact factor: 1.655

5.  Sustained vortex-like waves in normal isolated ventricular muscle.

Authors:  J M Davidenko; P F Kent; D R Chialvo; D C Michaels; J Jalife
Journal:  Proc Natl Acad Sci U S A       Date:  1990-11       Impact factor: 11.205

6.  Spontaneous oscillatory contraction without regulatory proteins in actin filament-reconstituted fibers.

Authors:  H Fujita; S Ishiwata
Journal:  Biophys J       Date:  1998-09       Impact factor: 4.033

7.  Comparison of the effects of 2,3-butanedione monoxime on force production, myosin light chain phosphorylation and chemical energy usage in intact and permeabilized smooth and skeletal muscles.

Authors:  M J Siegman; S U Mooers; T B Warren; D M Warshaw; M Ikebe; T M Butler
Journal:  J Muscle Res Cell Motil       Date:  1994-08       Impact factor: 2.698

8.  The effects of 2,3-butanedione monoxime on initial heat, tension, and aequorin light output of ferret papillary muscles.

Authors:  E M Blanchard; G L Smith; D G Allen; N R Alpert
Journal:  Pflugers Arch       Date:  1990-04       Impact factor: 3.657

9.  The effect of 2,3-butanedione 2-monoxime (BDM) on ventricular trabeculae from the avian heart.

Authors:  M A Brotto; R T Fogaça; T L Creazzo; R E Godt; T M Nosek
Journal:  J Muscle Res Cell Motil       Date:  1995-02       Impact factor: 2.698

10.  Electrophysiological and proarrhythmic parameters in transmural canine left-ventricular needle biopsies.

Authors:  S Cora Verduyn; Jérôme G M Jungschleger; Milan Stengl; Roel L H M G Spätjens; Jet D M Beekman; Marc A Vos
Journal:  Pflugers Arch       Date:  2004-10       Impact factor: 3.657

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.